Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/1/2025
Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...
7/1/2025
Hutchmed Receives China NMPA Approval for Lung Cancer Drug Combo, Trig...
7/1/2025
Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...
6/30/2025
BlissBio Advances Toward IPO with Focus on Next-Generation ADC Therapi...
6/30/2025
CTTQ's Anlotinib Wins Approval in China for First-Line Treatment of Ad...
6/30/2025
Cutia's Topical Finasteride Spray CU‑40102 Approved in China for Hair...
6/30/2025
Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...
6/30/2025
Conjupro Files USPTO Challenge on Ascletis' U.S. Patent for GLP‑1R Ag...
6/30/2025
QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....
6/30/2025
GenFleet IPO Highlights Promising RAS-Targeted Drug Pipeline
6/30/2025
China Medical System to Pursue Secondary Listing on Singapore Exchange
6/30/2025
China's Pharma Market Faces Mixed Performance in Q1 2025 Amid Shifting...
6/30/2025
China's Draft National Medical Security Law: Seven Key Highlights Sign...
6/30/2025
CDE Reopens Public Consultation on Revised Technical Guidelines for Co...
6/28/2025
I-Mab Unveils Encouraging Givastomig Results in First-Line Gastric Can...
6/28/2025
Innovent Wins Landmark China Approval for Obesity Drug Challenging Nov...
6/28/2025
China Raises Per Capita Public Health Funding to Support Seniors, Chil...
6/28/2025
China Releases Draft Medical Security Law for Public Comment
6/28/2025
Recent Official and Executive Moves
6/27/2025
CARsgen Submits NDA for Satri‑cel, Poised to Be First CAR‑T for Soli...
6/27/2025
Bayer and Tsinghua University Extend 16-Year Partnership to Advance Gl...
6/27/2025
Mabwell Strikes Major $596M Deal with Calico to Advance Anti-Aging IL-...
6/27/2025
Theravance Partner Viatris Lands NMPA Approval for YUPELRI, Unlocking ...
6/27/2025
Arbutus and Qilu End Partnership as Arbutus Regains Full Rights to Imd...
6/27/2025
Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...
6/27/2025
Analyzing Key Trends in China's Patent-Linkage System and Their Impact...
6/26/2025
Immvira Advances Toward HKSE Listing with Focus on Oncolytic Virus The...
6/26/2025
BrightGene Seeks Partner for Obesity Drug Aimed at Surpassing Zepbound
6/26/2025
Vor Bio Secures ex-China Global Rights to RemeGen's Telitacicept
6/25/2025
Breaking the Boundaries: A New Map of Physician Behavior in China's Di...
Page:
1
/
774
Total number of articles:
23207
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit